| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-07-09 16:18:30 UTC |
|---|
| Update Date | 2019-07-23 07:15:46 UTC |
|---|
| HMDB ID | HMDB0061101 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 2-oxobrimonidine |
|---|
| Description | 2-oxobrimonidine belongs to the class of organic compounds known as quinoxalines. Quinoxalines are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring. 2-oxobrimonidine is a very strong basic compound (based on its pKa). 2-oxobrimonidine is a metabolite of brimonidine. Brimonidine (bri-MOE-ni-deen, brand names Alphagan and Alphagan-P) is a drug used to treat open-angle glaucoma or ocular hypertension. As a treatment for glaucoma, it is usually given in eyedrop form. It acts via decreasing synthesis of aqueous humor, and increasing the amount that drains from the eye through uveoscleral outflow. |
|---|
| Structure | BrC1=C(NC2=NCCN2)C=CC2=C1N=CC(=O)N2 InChI=1S/C11H10BrN5O/c12-9-6(17-11-13-3-4-14-11)1-2-7-10(9)15-5-8(18)16-7/h1-2,5H,3-4H2,(H,16,18)(H2,13,14,17) |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C11H10BrN5O |
|---|
| Average Molecular Weight | 308.134 |
|---|
| Monoisotopic Molecular Weight | 307.006872614 |
|---|
| IUPAC Name | 5-bromo-6-[(4,5-dihydro-1H-imidazol-2-yl)amino]-1,2-dihydroquinoxalin-2-one |
|---|
| Traditional Name | 5-bromo-6-(4,5-dihydro-1H-imidazol-2-ylamino)-1H-quinoxalin-2-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | BrC1=C(NC2=NCCN2)C=CC2=C1N=CC(=O)N2 |
|---|
| InChI Identifier | InChI=1S/C11H10BrN5O/c12-9-6(17-11-13-3-4-14-11)1-2-7-10(9)15-5-8(18)16-7/h1-2,5H,3-4H2,(H,16,18)(H2,13,14,17) |
|---|
| InChI Key | BUVCZMAMYHMOPB-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as quinoxalines. Quinoxalines are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Diazanaphthalenes |
|---|
| Sub Class | Benzodiazines |
|---|
| Direct Parent | Quinoxalines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Quinoxaline
- Aryl bromide
- Aryl halide
- Pyrazine
- Benzenoid
- 2-imidazoline
- Heteroaromatic compound
- Guanidine
- Lactam
- Azacycle
- Carboximidamide
- Propargyl-type 1,3-dipolar organic compound
- Organic 1,3-dipolar compound
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organobromide
- Organohalogen compound
- Organic nitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.64 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.8265 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.39 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 778.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 266.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 88.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 171.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 80.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 304.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 325.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 325.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 648.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 236.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 887.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 217.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 202.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 545.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 329.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 112.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 2-oxobrimonidine,1TMS,isomer #1 | C[Si](C)(C)N(C1=NCCN1)C1=CC=C2[NH]C(=O)C=NC2=C1Br | 2838.5 | Semi standard non polar | 33892256 | | 2-oxobrimonidine,1TMS,isomer #1 | C[Si](C)(C)N(C1=NCCN1)C1=CC=C2[NH]C(=O)C=NC2=C1Br | 2635.0 | Standard non polar | 33892256 | | 2-oxobrimonidine,1TMS,isomer #1 | C[Si](C)(C)N(C1=NCCN1)C1=CC=C2[NH]C(=O)C=NC2=C1Br | 5206.5 | Standard polar | 33892256 | | 2-oxobrimonidine,1TMS,isomer #2 | C[Si](C)(C)N1CCN=C1NC1=CC=C2[NH]C(=O)C=NC2=C1Br | 2900.7 | Semi standard non polar | 33892256 | | 2-oxobrimonidine,1TMS,isomer #2 | C[Si](C)(C)N1CCN=C1NC1=CC=C2[NH]C(=O)C=NC2=C1Br | 2687.8 | Standard non polar | 33892256 | | 2-oxobrimonidine,1TMS,isomer #2 | C[Si](C)(C)N1CCN=C1NC1=CC=C2[NH]C(=O)C=NC2=C1Br | 4607.0 | Standard polar | 33892256 | | 2-oxobrimonidine,1TMS,isomer #3 | C[Si](C)(C)N1C(=O)C=NC2=C(Br)C(NC3=NCCN3)=CC=C21 | 2918.7 | Semi standard non polar | 33892256 | | 2-oxobrimonidine,1TMS,isomer #3 | C[Si](C)(C)N1C(=O)C=NC2=C(Br)C(NC3=NCCN3)=CC=C21 | 2679.3 | Standard non polar | 33892256 | | 2-oxobrimonidine,1TMS,isomer #3 | C[Si](C)(C)N1C(=O)C=NC2=C(Br)C(NC3=NCCN3)=CC=C21 | 5494.4 | Standard polar | 33892256 | | 2-oxobrimonidine,2TMS,isomer #1 | C[Si](C)(C)N1CCN=C1N(C1=CC=C2[NH]C(=O)C=NC2=C1Br)[Si](C)(C)C | 2716.3 | Semi standard non polar | 33892256 | | 2-oxobrimonidine,2TMS,isomer #1 | C[Si](C)(C)N1CCN=C1N(C1=CC=C2[NH]C(=O)C=NC2=C1Br)[Si](C)(C)C | 2712.1 | Standard non polar | 33892256 | | 2-oxobrimonidine,2TMS,isomer #1 | C[Si](C)(C)N1CCN=C1N(C1=CC=C2[NH]C(=O)C=NC2=C1Br)[Si](C)(C)C | 4193.9 | Standard polar | 33892256 | | 2-oxobrimonidine,2TMS,isomer #2 | C[Si](C)(C)N(C1=NCCN1)C1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C | 2805.6 | Semi standard non polar | 33892256 | | 2-oxobrimonidine,2TMS,isomer #2 | C[Si](C)(C)N(C1=NCCN1)C1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C | 2652.6 | Standard non polar | 33892256 | | 2-oxobrimonidine,2TMS,isomer #2 | C[Si](C)(C)N(C1=NCCN1)C1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C | 5142.7 | Standard polar | 33892256 | | 2-oxobrimonidine,2TMS,isomer #3 | C[Si](C)(C)N1CCN=C1NC1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C | 2866.2 | Semi standard non polar | 33892256 | | 2-oxobrimonidine,2TMS,isomer #3 | C[Si](C)(C)N1CCN=C1NC1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C | 2736.3 | Standard non polar | 33892256 | | 2-oxobrimonidine,2TMS,isomer #3 | C[Si](C)(C)N1CCN=C1NC1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C | 4533.5 | Standard polar | 33892256 | | 2-oxobrimonidine,3TMS,isomer #1 | C[Si](C)(C)N1CCN=C1N(C1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C)[Si](C)(C)C | 2715.3 | Semi standard non polar | 33892256 | | 2-oxobrimonidine,3TMS,isomer #1 | C[Si](C)(C)N1CCN=C1N(C1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C)[Si](C)(C)C | 2760.0 | Standard non polar | 33892256 | | 2-oxobrimonidine,3TMS,isomer #1 | C[Si](C)(C)N1CCN=C1N(C1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C)[Si](C)(C)C | 3912.4 | Standard polar | 33892256 | | 2-oxobrimonidine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=NCCN1)C1=CC=C2[NH]C(=O)C=NC2=C1Br | 3068.1 | Semi standard non polar | 33892256 | | 2-oxobrimonidine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=NCCN1)C1=CC=C2[NH]C(=O)C=NC2=C1Br | 2832.0 | Standard non polar | 33892256 | | 2-oxobrimonidine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=NCCN1)C1=CC=C2[NH]C(=O)C=NC2=C1Br | 5179.9 | Standard polar | 33892256 | | 2-oxobrimonidine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1CCN=C1NC1=CC=C2[NH]C(=O)C=NC2=C1Br | 3144.6 | Semi standard non polar | 33892256 | | 2-oxobrimonidine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1CCN=C1NC1=CC=C2[NH]C(=O)C=NC2=C1Br | 2882.6 | Standard non polar | 33892256 | | 2-oxobrimonidine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1CCN=C1NC1=CC=C2[NH]C(=O)C=NC2=C1Br | 4721.7 | Standard polar | 33892256 | | 2-oxobrimonidine,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(=O)C=NC2=C(Br)C(NC3=NCCN3)=CC=C21 | 3121.7 | Semi standard non polar | 33892256 | | 2-oxobrimonidine,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(=O)C=NC2=C(Br)C(NC3=NCCN3)=CC=C21 | 2888.9 | Standard non polar | 33892256 | | 2-oxobrimonidine,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(=O)C=NC2=C(Br)C(NC3=NCCN3)=CC=C21 | 5579.3 | Standard polar | 33892256 | | 2-oxobrimonidine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1N(C1=CC=C2[NH]C(=O)C=NC2=C1Br)[Si](C)(C)C(C)(C)C | 3124.9 | Semi standard non polar | 33892256 | | 2-oxobrimonidine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1N(C1=CC=C2[NH]C(=O)C=NC2=C1Br)[Si](C)(C)C(C)(C)C | 3082.4 | Standard non polar | 33892256 | | 2-oxobrimonidine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1N(C1=CC=C2[NH]C(=O)C=NC2=C1Br)[Si](C)(C)C(C)(C)C | 4180.2 | Standard polar | 33892256 | | 2-oxobrimonidine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C1=NCCN1)C1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C(C)(C)C | 3212.2 | Semi standard non polar | 33892256 | | 2-oxobrimonidine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C1=NCCN1)C1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C(C)(C)C | 3048.3 | Standard non polar | 33892256 | | 2-oxobrimonidine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C1=NCCN1)C1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C(C)(C)C | 5089.0 | Standard polar | 33892256 | | 2-oxobrimonidine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1CCN=C1NC1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C(C)(C)C | 3293.0 | Semi standard non polar | 33892256 | | 2-oxobrimonidine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1CCN=C1NC1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C(C)(C)C | 3117.9 | Standard non polar | 33892256 | | 2-oxobrimonidine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1CCN=C1NC1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C(C)(C)C | 4550.3 | Standard polar | 33892256 | | 2-oxobrimonidine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1N(C1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3293.9 | Semi standard non polar | 33892256 | | 2-oxobrimonidine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1N(C1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3301.8 | Standard non polar | 33892256 | | 2-oxobrimonidine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN=C1N(C1=CC=C2C(=C1Br)N=CC(=O)N2[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3932.1 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 2-oxobrimonidine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0fw9-1190000000-3c118cb8c426c950f319 | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 2-oxobrimonidine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-oxobrimonidine 10V, Positive-QTOF | splash10-0a4i-0009000000-9efa281c07fe28d33dd2 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-oxobrimonidine 20V, Positive-QTOF | splash10-0a4i-2029000000-0e6325c25c18251c7ca6 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-oxobrimonidine 40V, Positive-QTOF | splash10-015c-9030000000-cb539342741b0ee1fbd0 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-oxobrimonidine 10V, Negative-QTOF | splash10-0a4i-0019000000-0a8ec29a29d617c47734 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-oxobrimonidine 20V, Negative-QTOF | splash10-0a4i-1069000000-83a107a7ffd6d788d895 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-oxobrimonidine 40V, Negative-QTOF | splash10-01s6-5090000000-6c567ee33e8d03c8b296 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-oxobrimonidine 10V, Negative-QTOF | splash10-0a4i-0019000000-157e38d3f1da01f259ca | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-oxobrimonidine 20V, Negative-QTOF | splash10-0a4i-0139000000-85073c3578035b847b7c | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-oxobrimonidine 40V, Negative-QTOF | splash10-0a6r-8973000000-a9b7291750c4dce22e73 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-oxobrimonidine 10V, Positive-QTOF | splash10-0a4i-0009000000-88d92cd61d8241107230 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-oxobrimonidine 20V, Positive-QTOF | splash10-0a4i-0029000000-a83d3078f40ae0e993d9 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-oxobrimonidine 40V, Positive-QTOF | splash10-03dr-0291000000-e221fc3b49183e992181 | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|